We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Life Sciences

Life Sciences Law360 provides breaking legal news and analysis on the pharmaceutical and medical device industry. Coverage includes high-stakes litigation and policy developments that affect life sciences companies, as well as licensing deals, mergers, and other corporate transactions.



Sign up for a 7-day FREE trial today!



Latest News in Life Sciences

  • December 14, 2018

    $50M Released Early For 2nd-Priority Dow Implant Victims

    The Sixth Circuit has found the $2.35 billion Dow Corning settlement trust for women with defective breast implants can begin paying out $50 million in second-tier claims early, saying there was sufficient evidence that there will be money left over when the last of the first-tier claims are filed next year.

  • December 14, 2018

    Feds Fight To Keep Insys Grand Jury Instructions Secret

    Massachusetts federal prosecutors on Thursday fought a bid by Insys Therapeutics Inc. executives embroiled in an alleged conspiracy to bribe doctors into prescribing fentanyl-based drugs to disclose grand jury instructions, arguing the government did not wrongly explain the conspiracy charges.

  • December 14, 2018

    EpiPen MDL Attys Scolded For 'Mindless Bickering'

    A Kansas federal judge on Friday dressed down attorneys in multidistrict litigation over EpiPen price hikes for engaging in “mindless bickering” during a high-stakes deposition of Mylan NV’s chief executive officer.

  • December 14, 2018

    Covington & Burling Steers Merck's €2B Animal Tech Biz Buy

    New Jersey-based Merck & Co. Inc. said on Friday that it has agreed to buy all outstanding shares of privately-held animal intelligence technology group Antelliq Group for €2.1 billion ($2.4 billion) and assume its debt in a deal that was guided by Covington & Burling LLP.

  • December 14, 2018

    AstraZeneca Sues Again Over Breast Cancer Drug Patents

    AstraZeneca has hit more generic-drug makers with a patent infringement suit in New Jersey federal court over a generic alternative to Faslodex, its injection-administered drug for battling breast cancer past menopause.

See more Life Sciences news

Life Sciences

Areas of Coverage

  • AGENCIES
  • U.S. Consumer Product Safety Commission
  • U.S. Food and Drug Administration
  • U.S. Patent and Trademark Office
  • U.S. International Trade Commission
  • POLICY & REGULATION
  • Affordable Care Act
  • Federal Food, Drug, and Cosmetic Act
  • Antitrust and consumer protection controls
  • Drug and medical device lobbying
  • State and international life sciences legislation and regulation
  • ENFORCEMENT
  • Drug and medical device recalls
  • Drug safety actions
  • Pay-for-delay investigations
  • Merger reviews
  • LITIGATION
  • Patent disputes, including
  • Abbreviated New Drug Application litigation
  • Section 301 cases
  • Product safety suits over drugs and medical devices, including off-label marketing and failure-to-warn claims
  • Consumer litigation and class actions
  • Fraud and compliance suits
  • Antitrust disputes
  • Labor and employment suits
  • Shareholder and corporate governance disputes
  • Bankruptcy proceedings
  • TRANSACTIONS
  • Mergers, acquisitions, and joint ventures
  • Share buybacks and stock splits
  • Private equity deals
  • Patent-licensing agreements
  • PROFILES
  • Personnel moves
  • Profiles of life sciences practice groups

Readership

  • Life sciences lawyers at top law firms
  • Corporate counsel and compliance officers at Fortune 1000 companies
  • Executives and attorneys in the drug, biotechnology, and medical device industries
  • Information experts at law firms, agencies, and companies
  • Policymakers at federal and state agencies
  • Judges and court staff across the U.S.
  • Professors, students, and library staff at every accredited law school in the U.S.
  • Attorney and law firm marketing professionals